(Q71093213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

W H Nikolaizik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

M H Schöni

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

271-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

Endocrine and lung function in asthmatic children on inhaled corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influenc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

Corticosteroid treatment in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970407-9

10.1016/S0022-3476(96)70407-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8636828%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference